Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in non-diabetic obese patients
NCT00500370Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2007
- Primary completion
- Feb 2008
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of exenatide in obesity, sponsored by AstraZeneca. Started Jun 2007; status: completed.
02
Drugs
exenatide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00500370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00500370.